Emcure Pharmaceuticals Limited — Iron Exporter Profile
Indian Pharmaceutical Exporter · #8 for Iron · $10.6M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #8 Indian exporter of Iron with $10.6M in export value and 596 verified shipments. Emcure Pharmaceuticals Limited holds a 2.2% market share in Iron exports across 43 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Iron Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Iron?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $1.2M | 66 | 14.3% |
| THAILAND | $1.1M | 56 | 13.9% |
| RUSSIA | $995.6K | 20 | 12.2% |
| FRANCE | $787.6K | 57 | 9.6% |
| CHILE | $514.3K | 14 | 6.3% |
| SRI LANKA | $368.6K | 40 | 4.5% |
| COTE D IVOIRE | $346.5K | 11 | 4.2% |
| UZBEKISTAN | $345.6K | 10 | 4.2% |
| MAURITIUS | $280.4K | 70 | 3.4% |
| PANAMA | $219.7K | 6 | 2.7% |
Emcure Pharmaceuticals Limited exports Iron to 50 countries. The largest destination is MYANMAR accounting for 14.3% of Emcure Pharmaceuticals Limited's Iron shipments, followed by THAILAND (13.9%) and RUSSIA (12.2%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Iron from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| KHETAN COMPANY LIMITED | MYANMAR | $1.2M | 66 |
| SOTEX PHARMFIRM | RUSSIA | $945.6K | 19 |
| ALLIANCE PHARMA CO LIMITED | THAILAND | $414.1K | 18 |
| E.P.DIS(EURAPHARMA) | FRANCE | $354.0K | 22 |
| NOUVELLE PSP COTE D'IVOIRE | COTE D IVOIRE | $346.5K | 9 |
| ALLIANCE PHARMA CO., LTD. | THAILAND | $302.7K | 18 |
| PHARM-AND-TRADE LLC. | UZBEKISTAN | $295.6K | 9 |
| ALLIANCE PHARMA CO LTD | THAILAND | $274.8K | 14 |
| EMERCHEMIE NB (CEYLON) LIMITED | SRI LANKA | $260.0K | 28 |
| EMCURE PHARMA CHILE S.P.A. | CHILE | $259.6K | 7 |
Emcure Pharmaceuticals Limited supplies Iron to 107 buyers globally. The largest buyer is KHETAN COMPANY LIMITED (MYANMAR), followed by SOTEX PHARMFIRM (RUSSIA) and ALLIANCE PHARMA CO LIMITED (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Iron Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $148.4M worth of Iron through 14,943 shipments from 943 suppliers to 174 countries, serving 2,171 buyers globally. Emcure Pharmaceuticals Limited contributes $10.6M to this total, accounting for 2.2% of India's Iron exports. Emcure Pharmaceuticals Limited ships Iron to 50 countries through 107 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Iron Exports?
Emcure Pharmaceuticals Limited's average Iron shipment value is $17.8K per consignment, based on 596 shipments totaling $10.6M. The largest destination is MYANMAR (14.3% of Emcure Pharmaceuticals Limited's Iron exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Iron Exporters?
Emcure Pharmaceuticals Limited ranks #8 among 943 Indian Iron exporters with a 2.2% market share. The top 3 exporters are UNICHEM LABORATORIES LIMITED ($32.2M), ZYDUS LIFESCIENCES LIMITED ($21.6M), AMNEAL PHARMACEUTICALS PRIVATE LIMITED ($18.8M). Emcure Pharmaceuticals Limited processed 596 shipments to 43 destination countries.
What Iron Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS PRODUCTS LIKFERR 100 MG INJ 5X5 ML AMP ( IRON SUCROSE INJECTION USP 100MG/5ML ) | $600.0K | 12 |
| PHARMACEUTICALS PRODUCTS FINISHED PRODUCT OROFER 100 MG 550 MCG CAPSULE 5X2X10 IRON III HYDROXIDE POLYMALTOSE C | $350.0K | 7 |
| PHARMACEUTICAL PRODUCTS - ENCIFER 100 MGINJ 5X5 ML AMP ( IRON SUCROSE INJECTIONUSP 100MG/5ML ) | $334.4K | 19 |
| PHARMACEUTICAL PRODUCTS:ENCIFER 100 MG INJ 5X5 ML AMPIRON SUCROSE INJECTION USP100MG/5ML | $300.0K | 6 |
| ENCIFER INJECTION 5X5 ML ( IRON SUCROSE | $283.6K | 7 |
| PHARMACEUTICALS PRODUCTS FINISHED PRODUCT OROFER 100 MG 550 MCG CAPSULE 5X2X10 IRON III HYDROXIDE POLYMALTOSE | $250.0K | 5 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM : ENCIFER 100 MGINJ 5X5 ML AMP IRON SUCROSE INJECTIONUSP 100MG/5ML | $250.0K | 5 |
| PHARMACEUTICALS PRODUCTS(FINISHED PRODUCT)(GENERIC NAME) - OROFER 50 MG SYRUP 150 ML BT ( IRON [III] HYDROXIDE POLYMALTNOS | $230.1K | 6 |
| PHARMACEUTICALS PRODUCTS -(FINIS. PRODUCT) - OROFER 50 MG SYRUP 150 ML BT ( IRON[III] HYDROXIDE POLYMALTOSE COMPLEX SYR | $219.8K | 22 |
| PHARMACEUTICALS PRODUCTS - ( FINISHED PRODUCT) OROFER 50 MG SYRUP 150 ML BT ( IRON [III] HYDROXIDE POLYMALTOSE COMPLEX SNOS | $199.5K | 16 |
Emcure Pharmaceuticals Limited exports 327 distinct Iron formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS PRODUCTS LIKFERR 100 MG INJ 5X5 ML AMP ( IRO with 12 shipments worth $600.0K.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Iron Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $18.8M | 375 | 1 | $50.0K |
| 4 | INTAS PHARMACEUTICALS LIMITED | $16.5M | 1,319 | 18 | $12.5K |
| 8 | EMCURE PHARMACEUTICALS LIMITED ★ | $10.6M | 596 | 43 | $17.8K |
| 9 | STRIDES PHARMA SCIENCE LIMITED | $9.4M | 225 | 3 | $41.8K |
| 10 | RUBICON RESEARCH PRIVATE LIMITED | $9.1M | 322 | 1 | $28.2K |
Emcure Pharmaceuticals Limited ranks #8 among 943 Indian Iron exporters. Average shipment value of $17.8K compared to the market average of $157.4K. The closest competitors by value are AMNEAL PHARMACEUTICALS PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Iron Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,808 | 12.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,771 | 11.9% |
| NHAVA SHEVA SEA (INNSA1) | 1,262 | 8.4% |
| DELHI AIR CARGO ACC (INDEL4) | 1,230 | 8.2% |
| DELHI AIR | 1,025 | 6.9% |
| JNPT/ NHAVA SHEVA SEA | 707 | 4.7% |
| MUNDRA SEA | 632 | 4.2% |
| JNPT | 627 | 4.2% |
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Iron Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Iron, top products include Dolutegravir, Mycophenolate, Tenofovir, Melphalan, Atazanavir. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Iron — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Iron shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 634 individual customs records matching Emcure Pharmaceuticals Limited exporting Iron, covering 327 formulations to 50 countries via 107 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 174+ countries, 2,171+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Iron Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Iron exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Iron Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Iron. For current shipment-level data, contact TransData Nexus.